General Information of Drug (ID: DMS658R)

Drug Name
3-hydroxyoctanoic acid Drug Info
Synonyms 3-hydroxyoctanoate; 3-OH-octanoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
26613
ChEBI ID
CHEBI:37098
CAS Number
CAS 14292-27-4
TTD Drug ID
DMS658R

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ARI-3037MO DM9LNXS Cardiovascular disease BA00-BE2Z Phase 2 [3]
NIA-114 DM3ADQW Plaque psoriasis EA90.0 Clinical trial [4]
PMID17358052C5b DMR9TYV Discovery agent N.A. Investigative [5]
D-tryptophan DMKIML1 Discovery agent N.A. Investigative [6]
D-kynurenine DM0QZ6I Discovery agent N.A. Investigative [6]
5-methyl-5-(5-methylthiophen-3-yl)-4-oxo-4,5-dihydrofuran-2-carboxylic acid DMO37W4 Discovery agent N.A. Investigative [5]
4-(n-propyl)amino-3-nitrobenzoic acid DMP43HI Discovery agent N.A. Investigative [7]
2-hydroxyoctanoic acid DMMILJS Discovery agent N.A. Investigative [2]
PMID19524438C6o DMK5JB8 Discovery agent N.A. Investigative [8]
IBC 293 DM8J24A Discovery agent N.A. Investigative [9]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hydroxycarboxylic acid receptor 3 (HCAR3) TT8WFXV HCAR3_HUMAN Agonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2933).
2 Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J Biol Chem. 2009 Aug 14;284(33):21928-33.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b. J Med Chem. 2007 Apr 5;50(7):1445-8.
6 Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B. Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3930-4.
7 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6619-22.
8 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4207-9.
9 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b. J Med Chem. 2006 Feb 23;49(4):1227-30.